


Domain Therapeutics presents most recent developments of its BRET technology portfolio at AACR and ASPET events

Yposkesi to give talk on gene therapy vectors at Virtual Cell & Gene Meeting on the Mediterranean, April 6 – 9, 2021

Cell-Easy strengthens executive team with two new highly experienced members

Chiesi and Hephaï join forces to develop AI educational tool to improve inhaler use

OncoDiag raises €2.5M ($3M) to develop its diagnostic testing for early detection of cancer

Tollys welcomes Dr. Jean-Pierre Armand as member of its scientific advisory board

CVasThera secures €1.3 Million in first funding round

Accure Therapeutics enrols first patient in phase II clinical trial on acute optic neuritis with lead candidate ACT-01
